baber/WOPTO huggingface dataset:
Patent AU-2003210034-A1 (AU)
Title: High throughput system for producing recombinant viruses using site-specific recombination
Inventor: JUNG NEON C
IPC: C12N15/09
Filed: 2003-03-08
Abstract: Disclosed are the methods for producing recombinant viruses using site-specific recombination in vitro. In the present invention, circular viral genomic DNAs are digested with restriction enzymes to generate a linear form viral genomic DNAs flanked by site-specific recombination sites, and then are subjected to site-specific recombination with the desired genomic materials flanked by site-specific recombination sites in vitro. According to the present invention, since the site-specific recombination mixture can be applied to host cells without further procedures of selecting the desired recombinant viral genomic DNAs, it is possible to obtain numerous recombinant viruses rapidly at the same time. Thus, the present invention can be used as a high throughput system for generating and screening hundreds or thousands of recombinant viruses.
Patent AU-2003219958-A1 (AU)
Title: Polypeptide formulation
Inventor: REMMELE RICHARD L JR
IPC: A61K38/00
Filed: 2003-02-27
Abstract: The present invention relates to an aqueous pharmaceutical composition suitable for long-term storage of polypeptides containing an Fc domain of an immunoglobulin, methods of manufacture, methods of administration and kits containing same.
Patent AU-2003236965-A1 (AU)
Title: Chip on disc record carrier with integrated power supply
Inventor: KAHLMAN JOSEPHUS A H M
IPC: G11B7/004
Filed: 2003-06-04
Abstract: A system for rendering information from a record carrier is described. The record carrier ( 1 ) has an integrated circuit ( 4 ) build in. The chip communicates contactlessly with the device. Power for the chip ( 4 ) is generated from low frequency magnetic flux changes by a power supply coil integrated on the chip. The device has a read head ( 22 ) and a magnetic array ( 21 ) having a plurality of poles for generating a static magnetic field having areas with positive and negative magnetic flux for cooperating with the power supply coil, and drive means ( 26 ) for rotating the record carrier for scanning the track via the head ( 22 ) and for moving the integrated circuit ( 4 ) through the magnetic field for creating the low frequency magnetic flux changes.
Patent AU-2003241580-A1 (AU)
Title: Anti-igf-i receptor antibody
Inventor: SINGH RAJEEVA
IPC: C12P21/08
Filed: 2003-06-12
Abstract: DNAs, vectors, host cells and genetic constructs of antibodies, humanized antibodies, resurfaced antibodies, antibody fragments, derivatized antibodies, and conjugates of these molecules with cytotoxic agents, which specifically bind to and inhibit insulin-like growth factor-I receptor, antagonize the effects of IGF-I and are substantially devoid of agonist activity toward the insulin-like growth factor-I receptor. These molecules can be conjugated to cytotoxic agents for use in the treatment of tumors that express elevated levels of IGF-I receptor, such as breast cancer, colon cancer, lung cancer, ovarian carcinoma, synovial sarcoma and pancreatic cancer. These molecules can also be labeled for in vitro and in vivo diagnostic uses, such as in the diagnosis and imaging of tumors that express elevated levels of IGF-I receptor.
Patent AU-2003264582-A1 (AU)
Title: Apparatus and Method for Vascular Embolization
Inventor: ROSENBLUTH ROBERT F
IPC: A61B17/12
Filed: 2003-11-26
Abstract: Apparatus (10) for deploying an elongate, filamentous embolic device (12; 50) in a vascular site through a catheter (14), the embolic device (12; 50) having a proximal end, the apparatus (10) comprising a flexible, elongate, hollow deployment tube (16) having an axial passage (20) and a distal end; and a holding element (24) that resists radial expansion and that is fixed to the distal end of the deployment tube (16) and configured to hold the proximal end of the embolic device (12; 50) by frictional engagement, the holding element (24) having a base with an opening (26) that communicates with the axial passage (20); and method of deploying an elongate, filamentous embolic device (12; 50) in a vascular site.
Patent AU-2003266387-A1 (AU)
Title: Acid red 82 in mixtures
Inventor: SOMMERMANN THOMAS
IPC: C09D11/00
Filed: 2003-09-13
Abstract: The invention relates to mixtures containing the dye C.I. Acid Red 82 (formula IIb) and C.I. Acid Red 80 (formula IIc)
Patent AU-2003272774-A1 (AU)
Title: Multilayer stent
Inventor: CHANDRASEKARAN VERIVADA
IPC: A61F2/06
Filed: 2003-09-29
Abstract: An endoprosthesis, such as a stent, having a layer that can enhance the biocompatibility of the endoprosthesis, and methods of making the endoprosthesis are disclosed.
Patent AU-2003288003-A1 (AU)
Title: Quality control method for two-dimensional matrix codes on metallic workpieces, using an image processing device
Inventor: FROHLICH KONRAD
IPC: G01B11/00
Filed: 2003-11-06
Abstract: A quality control method for two-dimensional matrix codes on metallic workpieces, the codes being in the form of stamped marking dots is disclosed. The stamping process for the marking dots is carried out by a marking tool ( 17 ) with the aid of predetermined digital positional data. The corresponding image data is then recorded for analysis by an image processing device ( 22 ), exclusively at the locations that have been predetermined by the positional data, or additional image data that has been previously generated is also used for the analysis, to establish whether a correct marking dot with the required quality characteristics is present.
Patent AU-2003303203-A1 (AU)
Title: Deployable structure
Inventor: HEPPEL PETER
IPC: E04H15/40
Filed: 2003-12-19
Abstract: A structure having a first semi-rigid surface with a first curved edge, the first semi-rigid surface adapted to be rotatably secured to a reference to permit the first semi-rigid surface to assume a first position and a second position, and a first joint structure spanning the first semi-rigid surface to permit the first semi-rigid surface to be folded when in the first position and unfolded when in the second position. The structure includes a second semi-rigid surface having a second curved edge, the second semi-rigid surface adapted to be rotatably secured to the reference to permit the second semi-rigid surface to assume a first position and a second position. The first and second semi-rigid surfaces are joined together at their first and second curved edges by a second joint structure adapted to permit the first and second semi-rigid surfaces to fold approximately together when the first and second semi-rigid surfaces are in their first positions.
Patent WO-2004102679-A1 (WO)
Title: Generateur de puissance photovoltaique
Inventor: LASICH JOHN BEAVIS
IPC: F24S50/20
Filed: 2004-05-19
Abstract: L'invention concerne un générateur de puissance photovoltaïque comprenant un récepteur de lumière orientable comportant une ou plusieurs cellules photovoltaïques destinées à collecter la lumière, ainsi qu'une source de lumière supplémentaire servant à fournir une lumière supplémentaire dans des conditions prédéterminées. Le récepteur peut être orienté jusqu'à une position de réception dans laquelle il peut recevoir la lumière en provenance de la source de lumière supplémentaire, laquelle peut remplacer ou augmenter la lumière naturelle de sorte que la sortie de puissance du générateur augmente lorsque les niveaux de lumière ambiante ou naturelle sont insuffisants.
Patent AU-2004201946-A1 (AU)
Title: Web access to secure data
Inventor: HELLER NOAH
IPC: G06F21/33
Filed: 2004-05-07
Abstract: Controlling access to secure data and services by versatile computers outside a secure environment, which communicates with limited dedicated devices such as game consoles, over a secure network such as a virtual private network. The versatile computing devices obtain access over an insecure network, such as the Internet, through a trusted partner Web site that authenticates users of the site and relays requests to the secure environment. The Web site uses a certificate for a predefined level of secure access to the secure environment. A link is established between a user's Web ID authenticated by the Web site and a gamer tag used within the secure environment. Access is limited as a function of the Web ID, gamer tag, and a Web site partner ID. A Web cache stores and provides some secure data, minimizing disruption to the secure environment's primary function to service the dedicated devices. <IMAGE>
Patent AU-2004219040-A1 (AU)
Title: Mobility management in wireless networks
Inventor: GROENENDAAL JOHAN VAN DE
IPC: H04L12/28
Filed: 2004-02-26
Abstract: Systems and methods for tracking and managing mobile devices in a wireless network are provided. For example, the method can include discovering wireless devices connected to the wireless network, collecting association information from access points, with the association information from an access point including information identifying a current association between the access point and an associated wireless device, and providing a visualization of current associations between the access points and corresponding associated wireless devices. A conflict resolution engine may be provided for resolving conflicting access point associations.
Patent AU-2004221655-A1 (AU)
Title: Method for use in multiphase flow
Inventor: BIRCH PHILIP LLOYD
IPC: A61F2/06
Filed: 2004-03-18
Abstract: A method of reducing slugging of multiphase hydrocarbon fluids extracted from a well, the method comprising: 
providing a pipe having a helical first pipe portion wherein the centre line of the helical pipe portion follows a substantially helical path, and the pipe having a second pipe portion downstream of the helical pipe portion; 
passing the multiphase fluids along said helical pipe portion so as to induce swirl flow of said multiphase fluids in said helical pipe portion; and 
passing the multiphase fluids along said second pipe portion whereby said swirl flow continues for a distance downstream of said helical pipe portion in said second pipe portion whilst dying away.
Patent AU-2004255913-A1 (AU)
Title: Organosilicon compounds and their use
Inventor: DAISS JUERGEN
IPC: C07F7/08
Filed: 2004-06-18
Abstract: A compound of formula (I) or formula (II): wherein the variables are as defined in the claims.
Patent AU-2004270911-A1 (AU)
Title: Ferment activator based on lactic acid bacteria, and method of preparing a product using said activator
Inventor: MORNET ANNIE
IPC: A23C19/032
Filed: 2004-09-03
Abstract: The present invention relates to an activator for a lactic bacteria-based ferment, characterized in that it comprises at least: one reducing disaccharide, one non-reducing disaccharide, an alkaline metal salt and/or an alkaline earth metal salt. The invention also relates to the ferment which is activated by means of said activator. The present invention is also concerned with the process for preparing an industrial product or food product, characterized by the use of the activator.
Patent AU-2004291279-A1 (AU)
Title: Method for melting frozen, water-containing products
Inventor: SCHMIDT DIETER
IPC: A23L3/365
Filed: 2004-11-06
Abstract: Method for thawing frozen water-containing products by heating and stirring in a horizontal mixer.
Patent AU-2004295316-A1 (AU)
Title: Pack comprising a dispensing orifice created by overlapping portions of laminated packaging material.
Inventor: GOEPFERT SANDRA
IPC: B65D75/58
Filed: 2004-11-17
Abstract: The invention relates to a pack of products that can be dispensed from the pack through a dispensing orifice. The pack comprises a flexible film material. There are non-overlapping portions of film material, having a first thickness, and overlapping portions of film material having a second and third thickness. The overlapping portions of film material overlap with other overlapping portions of film material. The second and third thickness is less than the first thickness. <??>The invention also relates to a process of making such pack, in particular by the lamination of 2 or more layers of material to form the pack. <IMAGE>
Patent AU-2004298781-A1 (AU)
Title: Stabilized interferon liquid formulations
Inventor: CURTO MARIA DORLY DEL
IPC: A61K47/26
Filed: 2004-12-10
Abstract: Stabilized liquid pharmaceutical composition comprising an interferon (IFN) or an isoform, mutein, fused protein, functional derivative, active fraction or salt thereof, wherein said formulation is a solution that comprises a buffer, a cyclodextrin, an isotonicity agent and an anti-oxidant are described here. Preferably the interferon is interferon beta-1a and the cyclodextrin is HPBCD. These formulations are stable at room temperature, thus bringing the advantage of lower costs for formulation storage and increased safety for the patient with respect to possible “errors” during handling. As a matter of fact, having such formulations stable at room temperature reduces the risk of formation of degradation products potentially responsible for adverse events (e.g. immunogenicity).
Patent AU-2004300713-A1 (AU)
Title: Device and method for conversion into a transformed representation or for inversely converting the transformed representation
Inventor: GEIGER RALF
IPC: H04N7/30
Filed: 2004-07-05
Abstract: For converting first and second blocks of discrete values into a transformed representation, the first block is transformed according to a first transformation rule and then rounded. Then, the rounded transformed values are summed with the second block of original discrete values, to then process the summation result according to a second transformation rule. The output values of the transformation via the second transformation rule are again rounded and then subtracted from the original discrete values of the first block of discrete values to obtain a block of integer output values of the transformed representation. By this multi-dimensional lifting scheme, a lossless integer transformation is obtained, which can be reversed by applying the same transformation rule, but with different signs in summation and subtraction, respectively, so that an inverse integer transformation can also be obtained. Compared to a separation of a transformation in rotations, on the one hand, a significantly reduced computing complexity is achieved and, on the other hand, an accumulation of approximation errors is prevented.
Patent WO-2006007632-A1 (WO)
Title: Procédé de test et de diagnostic à domicile de la déficience auditive, et des problèmes de développement liés chez les bébés, les tout-petits et les enfants
Inventor: NOWOSIELSKI JANUSZ
Filed: 2005-07-15
Abstract: Cette invention concerne un procédé de détection d’une déficience auditive et des difficultés d’apprentissage liées chez un jeune enfant, le procédé comprenant : un dispositif manuel de stockage et d’émission de sons (1), le dispositif comprenant une pluralité de sons de test stockés numériquement de façon sélective étalonnés dans une fréquence filtrée prédéterminée spécifique et des intensités adaptées pour émettre des largeurs de bandes filtrées sur des fréquences basses, moyennes et hautes, les sons sont sélectionnés dans une plage de stimuli tels que des sons environnementaux complexes associés à des objets reconnaissables comprenant des cartes d’images/de mots, des jouets et analogue ; un moyen d’affichage d’images (6) comprenant une pluralité de représentations picturales des objets reconnaissables (5) ; le procédé comprenant le maintien du dispositif manuel de stockage et d’émission de sons à une distance mesurée (3) à partir d’un jeune enfant devant être testé (4) ; la sélection d’un son d’un objet prédéterminé correspondant à l’une des représentations picturales sur l’affichage d’images ; l’activation de l’émission sonore, ladite déficience auditive du jeune enfant devant être testé (4) est mesurée objectivement en observant le jeune enfant associer le son de l’objet sélectionné à l’une des représentations de la pluralité des représentations picturales (5) correspondant au son de l’objet par reconnaissance auditive/visuelle, les étapes du procédé pouvant être répétées pour des sons filtrés au préalable à des fréquences sélectionnées dans des largeurs de bandes filtrées.
Patent AU-2005200671-A1 (AU)
Title: Phased-array for tissue treatment
Inventor: GOVARI ASSAF
IPC: A61N7/02
Filed: 2005-02-15
Abstract: Apparatus is provided for ablating tissue of a patient by applying ultrasound energy to the tissue. The apparatus is typically delivered to the targeted tissue via a catheter and includes an ultrasound array, which is adapted to be driven as a phased array to concentrate the ultrasound energy on the targeted tissue while avoiding surrounding tissue.
Patent AU-2005254731-A1 (AU)
Title: Thienopyridone carboxamides and their medical use
Inventor: JANSSON KARL
IPC: C07D495/04
Filed: 2005-06-15
Abstract: A compound of formula (I) wherein R is methyl, ethyl, n-propyl, iso-propyl, n-butyl or allyl; R' is hydrogen, C1-C4 alkyl, C1-C3 alkoxy; halogen, trifluoromethyl or OCHxFy, R'' is hydrogen, fluoro or chloro, that R'' being fluoro or chloro only when R' is fluoro or chloro; R3 is hydrogen or C1-C5 alkyl R4 is hydrogen, CH2OCOC(CH3)3, pharmaceutically acceptable inorganic or organic cations, or COR4' wherein R4' is C1-C5 alkyl, phenyl, benzyl or phenethyl; R7 is methyl or ethyl; one of A and B is sulphur and the other is C-R2; when A is S, R2 is selected from hydrogen and methyl, with the proviso that R2 is methyl only when R3 is not hydrogen; and when B is S, R2 is hydrogen; and any tautomer thereof. A pharmaceutical composition comprising a compound of formula (I), a method of treating malignant tumours or diseases resulting from autoimmunity or pathologic inflammation.
Patent AU-2005266447-A1 (AU)
Title: Use of K-252a and kinase inhibitors for the prevention or treatment of HMGB1-associated pathologies
Inventor: BERTARIONE RAVA ROSSA LUISA
IPC: A61P1/04
Filed: 2005-07-29
Abstract: The present invention relates to the use of K-252a, a physiologically active substance produced by microorganisms, and of its salts or synthetic and/or chemically modified derivatives for the prevention or treatment of HMGB1 associated pathologies. More particularly, the present invention relates to the use of K-252a for the prevention or treatment of restenosis.
Patent WO-2006110958-A1 (WO)
Title: Système de verrou électrique
Inventor: KORVIN CHRIS
IPC: E05B47/06
Filed: 2006-04-21
Abstract: Cette invention concerne un système de verrou électrique incluant un processeur distant (1) connecté à un ensemble verrou électrique (2), et un ensemble lecteur (3) raccordé à l’ensemble verrou électrique (2). L’ensemble lecteur (3) comprend une antenne (26) qui reçoit un signal d’utilisateur émis par une étiquette de clé (4). Raccorder l’ensemble lecteur (3) et l’ensemble verrou électrique (2) simplifie la méthode d’installation du système.
Patent AU-2006203142-A1 (AU)
Title: Can opener
Inventor: WAN YIU CHUNG
IPC: B67B7/60
Filed: 2006-07-24
Abstract: A can opener (100) has two pivotable handle members (110 & 120) and a traction wheel (200) and a rotary cutter (300) movable by the handle members (110 & 120) respectively between an inoperative position in which the wheel (200) and cutter (300) are spaced apart for mounting onto a can and an operative position in which they are close together for turning and cutting the can. An operating lever (400) is pivotable back and forth. A first ratchet assembly (510) is driven by the lever (400) upon pivotal movement in one direction for rotating the wheel (200) in one direction. There is also a second ratchet assembly (520) driven by the lever (400) upon pivotal movement in the opposite direction for rotating the wheel (200) in the same direction, whereby upon said pivotal reciprocation the lever (400) rotates the wheel (200) in the same direction to operate the wheel (200) and cutter (300) continuously to turn and cut the can.
Patent AU-2006210779-A1 (AU)
Title: DR5 antibodies and uses thereof
Inventor: ADAMS CAMELLIA W
IPC: C07K16/28
Filed: 2006-01-31
Abstract: The invention concerns anti-DR5 antibodies with improved properties, compositions comprising such antibodies, methods and means for making such antibodies, and their therapeutic use, in particular in the treatment of cancer.
Patent AU-2006226535-A1 (AU)
Title: Composition based on vegetal extracts of Ajuga reptans for preventing hair loss, stimulating the growth of hair, regulating the production of sebum.
Inventor: BELLINVIA SALVATORE
IPC: A61Q7/00
Filed: 2006-03-21
Abstract: The present invention relates to preparations based on vegetal extracts of Ajuga reptans for favouring the growth of hair and stimulating the hair bulb. The preparations of the invention are in suitable formulations for oral administration or local application and are specifically suitable for the prevention and treatment of androgenic alopecia in males and females.
Patent WO-2007137345-A1 (WO)
Title: PLANT NUCLEIC ACIDS ASSOCIATED WITH CELLULAR pH AND USES THEREOF
Inventor: QUATTROCCHIO FRANCESCA
IPC: C12N15/05
Filed: 2007-05-28
Abstract: The present invention relates generally to the field of plant molecular biology and agents useful in the manipulation of plant physiological or biochemical properties. More particularly, the present invention provides genetic and proteinaceous agents capable of modulating or altering the level of acidity or alkalinity in a cell, group of cells, organelle, part or reproductive portion of a plant. Genetically altered plants, plant parts, progeny, subsequent generations and reproductive material including flowers or flowering parts having cells exhibiting an altered cellular pH compared to a non-genetically altered plant are also provided.
Patent WO-2008040098-A1 (WO)
Title: Polypeptides immunogènes issus de la boucle de clivage de l'hémagglutinine précurseur d'un virus de la grippe
Inventor: LI PENG
IPC: C07K16/10
Filed: 2007-10-04
Abstract: L'invention concerne des préparations de vaccin peptidique et un procédé d'immunisation contre la grippe A au moyen du peptide subHA0 provenant d'un sous-type du virus de la grippe A. Le peptide HA0 a une longueur de 16 acides aminés ou davantage, choisis à partir de l'intérieur de la boucle de clivage de maturation d'une hémagglutinine HA0 du virus de la grippe A, ou d'une séquence consensus de celui-ci. Le peptide HA0 est administré à la muqueuse, de préférence par voie intranasale, avec un adjuvant et un peptide T helper qui sollicite la réponse immunitaire à une immunité à médiation par Th2.
Patent AU-2007205658-A1 (AU)
Title: Luminescent transgenic non human animals, progeny, cell derivatives and uses thereof
Inventor: LOHMER STEFAN
IPC: G01N33/68
Filed: 2007-01-10
Abstract: It is described a stable recombinant stem cell able to express an apophotoprotein and produce a bioluminescent signal in the presence of a suitable chromophore as substrate in response to intracellular calcium concentration variation: methods for identifying agents modulating the differentiation of stem cells towards a specific cell lineage; methods for identifying a ligand able to stimulate a specific cell lineage target; methods for identifying an antagonist to ligand known to stimulate a specific cell lineage target uses of stable recombinant stem cells for in vitro testing of toxicity and/teratology of a substance.
Patent AU-2007214766-A1 (AU)
Title: Aminoacyl prodrug derivatives and medicaments for the treatment of thromboembolitic disorders
Inventor: PERZBORN ELISABETH
IPC: A61K31/422
Filed: 2007-02-06
Abstract: The present application relates to prodrug derivatives of 5-chloro-N-({(5S)-2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)thiophene-2-carboxamide, processes for their preparation, their use for the treatment and/or prophylaxis of diseases, and their use for the manufacture of medicaments for the treatment and/or prophylaxis of diseases, especially of thromboembolic disorders.